Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 21, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Allen Klee Maintained (AUGX) at Strong Buy with Increased Target to $8 on, Apr 21st, 2023
Allen Klee of Maxim Group, Maintained "Augmedix, Inc." (AUGX) at Strong Buy with Increased Target from $5 to $8 on, Apr 21st, 2023.
Allen has made no other calls on AUGX in the last 4 months.
There is 1 other peer that has a rating on AUGX. Out of the 1 peers that are also analyzing AUGX, 0 agree with Allen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Allen
- Neil Chatterji of "B. Riley Securities" Reiterated at Strong Buy with Increased Target to $5 on, Thursday, April 20th, 2023
